Right time for Sun Pharma to buy Ranbaxy: Ramesh Adige
Ramesh Adige, former executive director of Ranbaxy, talks about Sun Pharma's acquisition of Ranbaxy. He says, "Ranbaxy's problem with US FDA can't get more intense than they are already, things can only improve from now onwards."
